104 results found
Searchresult 1 - 10 of 104. You filter by “News” and “Healthcare”.
ACM extends its investigation into the orphan drug CDCA manufactured by Leadiant. The investigation focuses on the pricing of the drug, and on possible abuse of a dominant position.
ACM studies: the insured’s diversity of wishes affects the negotiation balance between health insurers and hospitals
Health insurers must constantly find the right balance between the various wishes of insured. That affects their position in negotiations with hospitals.
ACM: Health insurers are allowed to give health care providers financial support collectively during Coronavirus crisis
Health insurers can make collective arrangements to support health care providers during the Coronavirus (COVID-19) crisis. These arrangements concern continuity contributions and advances on payments to health care providers that are not directly involved in helping Coronavirus patients.
Many forms of collaborations are allowed. However, collaborations can also go too far. That is why ACM has provided more clarity in its ‘Policy Rule on the Right Care in the Right Place’.
ACM has cleared the acquisition of health care provider Trimenzo by rival provider Sensire. Both organizations provide health care services such as district nursing and nursing home care. With this acquisition, Sensire is able to continue Trimenzo’s health care services.
Further investigation needed into merger of three geriatric-care providers in the south of the Netherlands
Dutch health care providers Stichting Schakelring, Stichting De Riethorst Stromenland and Stichting Volckaert wish to merge. Further investigation is needed into the merger’s effects in the markets for geriatric-rehabilitation care and post-acute rehabilitation services.